Zobrazeno 1 - 5
of 5
pro vyhledávání: '"T. Buitenkamp"'
Autor:
S. Elitzur, A. Vora, B. Burkhardt, H. Inaba, A. Attarbaschi, A. Baruchel, G. Escherich, B. Gibson, H. Liu, M. Loh, A. Moorman, A. Moricke, R. Pieters, A. Uyttebroeck, S. Baird, J. Bartram, M. Ben-Harosh, Y. Bertrand, T. Buitenkamp, K. Caldwell, R. Drut, A. Geerlinks, J. Grainger, S. Haouy, N. Heaney, M. Huang, D. Ingham, Z. Krenova, M. Kuhlen, T. Lehrnbecher, A. Manabe, F. Niggli, C. Paris, S. Revel-Vilk, P. Rohrlich, B. Sandeep, M. Sinno, T. Szczepanski, M. Tamesberger, R. Warrier, M. Wolfl, R. Nirel, S. Izraeli, A. Borkhardt, K. Schmiegelow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b67ca7a259349049dcf564b40e45be
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/103537
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/103537
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
V H J van der Velden, Marjolein Blink, T. Buitenkamp, E. R. Van Wering, J.P. van Wouwe, Christian M. Zwaan
Publikováno v:
Tijdschrift voor Kindergeneeskunde, 77(2), 52-58. Bohn Stafleu van Loghum
Children with Down syndrome (DS) have an increased risk for developing both acute myeloid as well as acute lymphoblastic leukemia. These leukemias differ in clinical characteristics and biology compared to leukemias in non-DS children. Moreover, chil
Autor:
Christian M. Zwaan, T. Buitenkamp, A. A. Danen-van Oorschot, M.M. van den Heuvel-Eibrink, Rob Pieters, E. R. Van Wering
Publikováno v:
Blood. 112:1518-1518
Children with Down Syndrome (DS) have an increased risk of developing leukemia, including both acute myeloid (ML DS), as well as acute lymphoblastic leukemia (DSALL). Recently, Izraeli et al. reported on an activating mutation (R683) localized in exo
Autor:
Christian M. Zwaan, Rob Pieters, M. Van Den Heuvel, E. R. Van Wering, R. Mathot, T. Buitenkamp, A. Vulto, Anjo J.P. Veerman
Publikováno v:
Blood. 112:1626-1626
Children with Down Syndrome (DS) have an increased risk of developing leukemia, including both acute myeloid, as well as acute lymphoblastic leukemia (DS-ALL). DS ALL patients have a poorer tolerance for high-dose methotrexate (HD-MTX), which is one